CATALOG PRODUCT FINDER
SEARCH BY KEYWORD:
SEARCH BY SCIENTIFIC FIELD:
Human PRAME Products
Select your Human PRAME Products including PepMix™ Peptide Pools, MHC-Dextramer, Antigen Peptide or Replitope™ Peptide Arrays!
PepMix™ Peptide Pools
PM-OIP4
PepMix™ Human (Prame/OIP4)
Pool of 125 peptides derived from a peptide scan through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) of Homo sapiens (Human)
Pool of 125 peptides derived from a peptide scan through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) of Homo sapiens (Human)

PepMix™ Human (Prame/OIP4)

Application |
Antigen specific T-cell stimulation Cancer biomarker research Immune monitoring T-cell assays T-cell expansion |
Protein Name | Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) |
Organism | Homo sapiens (Human) |
Indication / Topic |
Cancer Melanoma |
Number of peptides | 125 |
Further Information:
Amount | 1 vial containing 15 nmol (appr. 25µg) per peptide |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
NCBI | NP_996839 |
Sequence |
MERRRLWGSIQSRYISMSVWTSPRRLVE LAGQSLLKDEALAIAALELLPRELFPPL FMAAFDGRHSQTLKAMVQAWPFTCLPLG VLMKGQHLHLETFKAVLDGLDVLLAQEV RPRRWKLQVLDLRKNSHQDFWTVWSGNR ASLYSFPEPEAAQPMTKKRKVDGLSTEA EQPFIPVEVLVDLFLKEGACDELFSYLI EKVKRKKNVLRLCCKKLKIFAMPMQDIK MILKMVQLDSIEDLEVTCTWKLPTLAKF SPYLGQMINLRRLLLSHIHASSYISPEK EEQYIAQFTSQFLSLQCLQALYVDSLFF LRGRLDQLLRHVMNPLETLSITNCRLSE GDVMHLSQSPSVSQLSVLSLSGVMLTDV SPEPLQALLERASATLQDLVFDECGITD DQLLALLPSLSHCSQLTTLSFYGNSISI SALQSLLQHLIGLSNLTHVLYPVPLESY EDIHGTLHLERLAYLHARLRELLCELGR PSMVWLSANPCPHCGDRTFYDPEPILCP CFMPN |
Protein Length (aa) | 509 |

Dextramers®
MHC3428
MHC I Dextramer HLA-A*0201 (ALYVDSLFFL)
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells

MHC I Dextramer HLA-A*0201 (ALYVDSLFFL)

Application |
Immune monitoring Immunohistochemistry T-cell assays |
Protein Name | Selected proteins |
Organism |
BK polyomavirus Epstein-Barr virus (HHV-4) Hepatitis B virus Hepatitis C virus Homo sapiens (Human) Human adenovirus Human cytomegalovirus (HHV-5) Human immunodeficiency virus (HIV) Human papillomavirus Human respiratory syncytial virus Influenza A M. tuberculosis Mus musculus (mouse) Vaccinia virus Yellow fever virus |
Indication / Topic | Cancer |
Allele | HLA-A*0201 |
Peptide | ALYVDSLFFL |
Antigen | PRAME |
Category | Cancer |
Further Information:
Amount | 1 vial containing 50 /150 / 500 or 1000 tests |
Specifications | Antigen specific MHC class I multimer with dextran backbone |
Documentation | Protocol and Datasheet |
Protein Length (aa) | 0 |

MHC3312
MHC I Dextramer HLA-A*0201 (VLDGLDVLL)
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells

MHC I Dextramer HLA-A*0201 (VLDGLDVLL)

Application |
Immune monitoring Immunohistochemistry T-cell assays |
Protein Name | Selected proteins |
Organism |
BK polyomavirus Epstein-Barr virus (HHV-4) Hepatitis B virus Hepatitis C virus Homo sapiens (Human) Human adenovirus Human cytomegalovirus (HHV-5) Human immunodeficiency virus (HIV) Human papillomavirus Human respiratory syncytial virus Influenza A M. tuberculosis Mus musculus (mouse) Vaccinia virus Yellow fever virus |
Indication / Topic | Cancer |
Allele | HLA-A*0201 |
Peptide | VLDGLDVLL |
Antigen | PRAME |
Category | Cancer |
Further Information:
Amount | 1 vial containing 50 /150 / 500 or 1000 tests |
Specifications | Antigen specific MHC class I multimer with dextran backbone |
Documentation | Protocol and Datasheet |
Protein Length (aa) | 0 |

Antigen Peptides
SP-MHCI-0025
Antigen Peptide PRAME HLA-A*0201 (ALYVDSLFFL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Antigen Peptide PRAME HLA-A*0201 (ALYVDSLFFL)

Sequence | ALYVDSLFFL |
Category | TAA |
Allele | HLA-A*0201 |
Species | Homo sapiens (Human) |
Antigen | PRAME |
Uniprot ID | P78395 |
Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) |
Organism | Homo sapiens (Human) |
Indication / Topic |
Cancer Melanoma |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | 10mer peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID | |
Sequence | H-ALYVDSLFFL-OH |
Protein Length (aa) | 0 |

RepliTope™ Peptide Microarrays
RT-MW-OIP4
Multiwell RepliTope™ Human (Prame/OIP4)
Peptide microarray displaying 125 peptides derived from a peptide scan through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) of Homo sapiens (Human). Incubation with 20 samples (and one control) in parallel using the Array Slide 24-4 ch
Peptide microarray displaying 125 peptides derived from a peptide scan through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) of Homo sapiens (Human). Incubation with 20 samples (and one control) in parallel using the Array Slide 24-4 ch

Multiwell RepliTope™ Human (Prame/OIP4)

Application |
Antibody epitope discovery Cancer biomarker research Immune monitoring |
Protein Name | Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) |
Organism | Homo sapiens (Human) |
Indication / Topic |
Cancer Melanoma |
Number of peptides | 125 |
Further Information:
Amount | 1 peptide microarray (each peptide is deposited 3x per subarray, 21 subarrays per slide) |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol, Datasheet, gal-file and gal-viewer |
Swiss-Prot ID | |
NCBI | NP_996839 |
Sequence |
MERRRLWGSIQSRYISMSVWTSPRRLVE LAGQSLLKDEALAIAALELLPRELFPPL FMAAFDGRHSQTLKAMVQAWPFTCLPLG VLMKGQHLHLETFKAVLDGLDVLLAQEV RPRRWKLQVLDLRKNSHQDFWTVWSGNR ASLYSFPEPEAAQPMTKKRKVDGLSTEA EQPFIPVEVLVDLFLKEGACDELFSYLI EKVKRKKNVLRLCCKKLKIFAMPMQDIK MILKMVQLDSIEDLEVTCTWKLPTLAKF SPYLGQMINLRRLLLSHIHASSYISPEK EEQYIAQFTSQFLSLQCLQALYVDSLFF LRGRLDQLLRHVMNPLETLSITNCRLSE GDVMHLSQSPSVSQLSVLSLSGVMLTDV SPEPLQALLERASATLQDLVFDECGITD DQLLALLPSLSHCSQLTTLSFYGNSISI SALQSLLQHLIGLSNLTHVLYPVPLESY EDIHGTLHLERLAYLHARLRELLCELGR PSMVWLSANPCPHCGDRTFYDPEPILCP CFMPN |
Protein Length (aa) | 509 |

RT-OIP4
RepliTope™ Human (Prame/OIP4)
Peptide microarray displaying 125 peptides derived from a peptide scan through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) of Homo sapiens (Human)
Peptide microarray displaying 125 peptides derived from a peptide scan through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) of Homo sapiens (Human)

RepliTope™ Human (Prame/OIP4)

Application |
Antibody epitope discovery Cancer biomarker research Immune monitoring |
Protein Name | Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) |
Organism | Homo sapiens (Human) |
Indication / Topic |
Cancer Melanoma |
Number of peptides | 125 |
Further Information:
Amount | 1 peptide microarray (each peptide is deposited 3x per subarray, 4 subarrays per slide) + dummy slide and spacers (needed for manual incubation) |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol, Datasheet, gal-file and gal-viewer |
Swiss-Prot ID | |
NCBI | NP_996839 |
Sequence |
MERRRLWGSIQSRYISMSVWTSPRRLVE LAGQSLLKDEALAIAALELLPRELFPPL FMAAFDGRHSQTLKAMVQAWPFTCLPLG VLMKGQHLHLETFKAVLDGLDVLLAQEV RPRRWKLQVLDLRKNSHQDFWTVWSGNR ASLYSFPEPEAAQPMTKKRKVDGLSTEA EQPFIPVEVLVDLFLKEGACDELFSYLI EKVKRKKNVLRLCCKKLKIFAMPMQDIK MILKMVQLDSIEDLEVTCTWKLPTLAKF SPYLGQMINLRRLLLSHIHASSYISPEK EEQYIAQFTSQFLSLQCLQALYVDSLFF LRGRLDQLLRHVMNPLETLSITNCRLSE GDVMHLSQSPSVSQLSVLSLSGVMLTDV SPEPLQALLERASATLQDLVFDECGITD DQLLALLPSLSHCSQLTTLSFYGNSISI SALQSLLQHLIGLSNLTHVLYPVPLESY EDIHGTLHLERLAYLHARLRELLCELGR PSMVWLSANPCPHCGDRTFYDPEPILCP CFMPN |
Protein Length (aa) | 509 |

News
13 NEW Immunopeptidomics Kits
References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more
Infectious diseases beyond COVID-19
JPT's peptide formats in the literature
(Oct 2020)
Read more
SARS COV-2 Mass Spec Reference Kit Released!:
SARS-CoV-2 SpikeMix for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more
New! SARS-CoV-2 Epitope Mapping Peptide Sets
Save time and samples and check our new SARS-CoV-2 Epitope Mapping Peptide Sets (EMPS).
(Apr 2020)
Read more
Quality Assurance
All production is performed according to ISO 9001:2015 standards.